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he ontogeny of bone marrow and its stromal com-
partment, which is generated from skeletal stem/
progenitor cells, was investigated in vivo and ex
vivo in mice expressing constitutively active parathyroid
hormone/parathyroid hormone–related peptide recep-
tor (PTH/PTHrP; caPPR) under the control of the 2.3-kb
bone-speciﬁc mouse Col1A1 promoter/enhancer. The trans-
gene promoted increased bone formation within pro-
spective marrow space, but delayed the transition
from bone to bone marrow during growth, the formation
of marrow cavities, and the appearance of stromal cell
T
 
types such as marrow adipocytes and cells supporting
hematopoiesis. This phenotype resolved spontaneously
over time, leading to the establishment of marrow con-
taining a greatly reduced number of clonogenic stromal
cells. Proliferative osteoprogenitors, but not multipotent
skeletal stem cells (mesenchymal stem cells), capable of
generating a complete heterotopic bone organ upon in
vivo transplantation were assayable in the bone marrow
of caPPR mice. Thus, PTH/PTHrP signaling is a major
regulator of the ontogeny of the bone marrow and its
stromal tissue, and of the skeletal stem cell compartment.
 
Introduction
 
Postnatal bone marrow is composed of two distinct tissues and
hosts a dual system of stem cells. Hematopoietic tissue proper
includes a range of maturing hematopoietic cells originating
from the proliferation, commitment, and differentiation of
blood-borne hematopoietic stem cells (HSCs) and progenitors,
which seed the marrow (Morrison et al., 1995). The stroma,
which permits hematopoiesis by providing appropriate envi-
ronmental cues, is instead derived from the same lineage as
cartilage and bone cells, and is established during bone de-
velopment (Bianco and Riminucci, 1998). Postnatal marrow
stroma also includes a hierarchy of skeletal stem cells (SSCs;
also referred to as stromal stem cells or mesenchymal stem
cells) and progenitors (Friedenstein, 1980; Owen and Friedenstein,
1988; Bianco and Robey, 2000, 2004), which give rise to
different kinds of skeletal cells, contribute to skeletal growth,
maintain skeletal mass, and convey the remarkable potential
for repair and regeneration with which bone is endowed (Bianco
et al., 1999). SSCs and committed osteoprogenitors (OPs) are
both found in the clonogenic subset of adherent bone marrow
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cells, which are nonhematopoietic, nonendothelial, nonphago-
cytic, and fibroblastic in habit, and therefore regarded as stro-
mal in nature. These cells, referred to as clonogenic stromal
cells or colony-forming unit–fibroblasts (CFU-Fs), initiate the
growth of discrete colonies upon plating at low cell density.
Presently, SSCs and OPs cannot be distinguished from one an-
other by a defined surface phenotype. Assessments of CFU-F
frequencies in marrow through appropriate clonogenic effi-
ciency assays thus estimate the size of the total population of
stem cells/progenitors in a marrow sample, without directly
probing the presence, or estimating the specific frequency, of
SSCs. Nonetheless, SSCs and OPs are endowed with distinct
growth and differentiation potential, as is revealed by in vivo
transplantation assays (Bianco et al., 1999). SSCs are those sin-
gle CFU-Fs that generate progeny in culture that are capable of
forming bone and nonhematopoietic elements of marrow upon
ex vivo expansion and subsequent transplantation (Bianco and
Robey, 2004). By establishing a complete ectopic bone/mar-
row organ that survives for the recipient animal’s lifespan,
these cells demonstrate multipotency and self-renewal; they are
established in culture as marrow stromal cells, and, after many
population doublings ex vivo, regenerate marrow stromal cells
in vivo. OPs, in contrast, are those single CFU-Fs that generate
progeny capable of forming bone, but not a complete bone/
marrow organ, upon transplantation in vivo (Chailakhyan et al.,
1978; Kuznetsov et al., 1997). In mice, 
 
 
 
10% of CFU-Fs rep-
resent in vivo assayable SSCs, and 
 
 
 
25% represent differentia-
tion-restricted (committed) OPs (Chailakhyan et al., 1978).
Mechanisms that regulate hematopoietic marrow devel-
opment in bone, establishment of stroma, and the ontogeny of
SSCs and committed OPs have remained largely unexplored.
Their interplay with developmental events that establish the
shape, structure, size, and mass of bones remains, likewise, to
be elucidated. These mechanisms must operate in the context
of endochondral bone formation, the organogenic process by
which most bones, and the marrow that fills them, develop. En-
dochondral bone formation is characterized by a precisely
timed sequence of tissue transitions (Streeter, 1949). Formation
of the embryonic anlagen, which is made of hyaline cartilage,
is followed by the emergence of primary ossification centers in
its midst. Here, chondrocytes hypertrophy, and their matrix cal-
cifies and is invaded by blood vessels and osteogenic cells mi-
grating from the surrounding perichondrium. Calcified carti-
lage is resorbed by osteoclasts and then replaced by bone (the
primary spongiosa). With continuing resorption of the primary
spongiosa, the primary center splits into two opposite physes
(growth plates), in each of which cartilage maturation to hyper-
trophy and calcification, and subsequent remodeling into bone,
continue as long as new chondrocytes are generated in the
growth plate. As chondrocyte proliferation/differentiation fuels
longitudinal bone growth during postnatal life, the physes are
separated by increasing amounts of bone and marrow, consist-
ing of hematopoietic cells held in a network of stromal cell pro-
cesses (Streeter, 1949). Cartilage matures to hypertrophic and
calcified cartilage, before it is resorbed and replaced by bone.
Bone formed by this process is then resorbed and replaced by
newer bone (secondary spongiosa), and this is ultimately re-
placed by marrow. Therefore, during endochondral bone for-
mation a similar principle of timed remodeling of one tissue
into another governs both the formation of metaphyseal bone to
replace cartilage and the formation of marrow to replace meta-
physeal bone.
Substantial advances have been made in the identification
of genes regulating cartilage growth, maturation, and replace-
ment by bone during endochondral ossification (de Crombrug-
ghe et al., 2001). Little insight has been gained, however, into
mechanisms that establish, through the same organogenic pro-
cess, the bone marrow and its dual stem cell system, or the crit-
ical, functional interplay of hematopoietic and stromal cells.
The pivotal role of parathyroid hormone/parathyroid hormone–
related peptide (PTH/PTHrP) signaling in regulating cartilage-
based transitions in endochondral bone formation was high-
lighted by development of PTHrP- and PTH/PTHrP receptor
(PPR)–deficient mice (Karaplis et al., 1994; Lanske et al.,
1996). In both models, ablation of PPR signaling caused early
cessation of chondrocyte proliferation, accelerated maturation
to hypertrophic chondrocytes, premature ossification in growth
plates, and severe dwarfism. Conversely, enhanced PPR signal-
ing in chondrocytes has the opposite effect; that is, it causes de-
layed maturation. Constitutively active PPR (caPPR), usually
the result of an H223R mutation, causes Jansen-type meta-
physeal chondrodysplasia (Schipani et al., 1995, 1996). Targeted
expression of caPPR in cartilage rescues the phenotype of
PTHrP knockout mice (Schipani et al., 1997). When targeted
to chondrocytes in the PTHrP-sufficient mouse, expression of
caPPR caused a marked delay in maturation to hypertrophy
(Schipani et al., 1997). Lack of invasion of prenatal cartilage
anlagen in these mice delayed formation of the primary spon-
giosa and of a marrow cavity.
Targeting of caPPR to cells of the osteogenic lineage
(Col1-caPPR) in mice results in another distinct phenotype,
dominated by marked increases in bone mass and turnover in
postnatal long bones (Calvi et al., 2001). Here, we show that
Col1-caPPR induces a complex derangement in the ontogeny,
kinetics, and biological properties of the bone marrow stromal
system. By regulating the timed transition between bone and
marrow during bone growth, PPR regulates the establishment
of the hematopoietic stroma and of stromal stem cells therein.
 
Results
 
Col1-caPPR delays establishment of 
hematopoiesis in bone
 
At 2 wk, the marrow cavity was well formed in the femur and
tibia of wild-type (wt) mice, and clearly detectable by X-ray
imaging. In contrast, the marrow cavity of Col1-caPPR trans-
genic (tg) mice was reduced to a small mid-diaphyseal region
because of a marked extension of the primary spongiosa from
the metaphyses into the diaphyses (Fig. 1, a and b). Histologi-
cally, the excess bone of tg mice was composed of bone trabec-
ulae lined by normal-appearing osteoblasts. The area between
the trabeculae was occupied by fibroblastoid cells, blood ves-
sels, and osteoclasts, but devoid of hematopoietic cells, at 2
wk. Marrow was confined to a small diaphyseal region corre- 
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sponding to the radiographically detectable marrow cavity in tg
mice, whereas it extended from one metaphyseal spongiosa to
the other in wt long bones (Fig. 1, c and d).
High resolution microradiographs of 100-
 
 
 
m sections
clearly showed the formation of excess (medullary) bone in
the metaphyseal and upper diaphyseal regions of tg tibiae
(Fig. 1 e). Microcomputerized tomography (microCT) analy-
sis of tibiae and fibulae demonstrated that a distinct, bone-
free marrow cavity was well apparent 0.5 mm below the phy-
sis in both wt bones (Fig. 1 f). In tg mice, the marrow cavity
was partially occupied by bone trabeculae for 2–3 mm below
the physis in the tibia, and no cavity was discernible in the
fibula. In both bones of tg mice, a continuous plexus of can-
cellous bone trabeculae effaced the spatial and structural dis-
tinctions between marrow space and cortical bone observed in
wt mice (Fig. 1 f).
 
Col1-caPPR impairs marrow adipogenesis
 
Either red (hematopoietic) or yellow (adipose) marrow occupies
specific regions in the mammalian skeleton (Tavassoli and Yof-
fey, 1983). In mice, the entire marrow cavity of the calcaneum is
occupied by yellow marrow at skeletal maturity. Histological
analysis of the calcaneum at 2 wk and 3 mo revealed that a tran-
sient phase of active hematopoiesis (red marrow) precedes the
establishment of yellow marrow in wt mice (Fig. 2 a). At 2 wk,
the marrow cavity of the calcaneum was well defined and con-
tained abundant hematopoietic cells and developing adipocytes,
recognizable by their typical multivacuolar morphology (Fig. 2,
c and inset), similar to what is observed during phases of active
adipogenesis in other species. No hematopoiesis or adipogenesis
was seen in 2-wk-old tg calcaneum, in which a continuous tra-
becular bone structure was seen instead (Fig. 2, b and d). At 3
mo, formation of a thick bony cortex and yellow marrow filling
the cavity were complete in wt mice (Fig. 2 e). In contrast, a
marked excess of bone filled the marrow cavity in tg calcaneum,
and only rare adipocytes were scattered in the narrow vascular
spaces remaining patent (Fig. 2 f).
 
Temporal changes in bone and marrow 
structure in Col1-caPPR mice
 
Radiographic analysis at multiple time points demonstrated an
obvious evolution of the phenotype in tg mice over time (Fig.
3). Remodeling of the extended primary spongiosa into a sec-
Figure 1. Impaired development of the
marrow cavity and hematopoietic tissue in
long bones of COL1-caPPR mice. (a) High reso-
lution radiograms of the femurs of wt and tg
mice at 2 wk. Note the marked difference in
length of the marrow cavity (arrows). (b) High
resolution radiograms of tibiae and fibulae of wt
and tg mice at 2 wk. Note the different lengths
of the primary spongiosa (arrows). (c and d)
Histological sections of the distal metaphysis of
the femur (c) and proximal metaphysis of the
tibia (d) at 2 wk. Red marrow extends to the
metaphyseal end of the primary spongiosa in
wt mice (arrows), but only medullary bone is
present in tg mice. (e and f) High resolution
contact microradiography (e) and microCT
analysis (f) of tibiae at 2 wk. The excess medul-
lary bone formed in tg mice is obvious with
both techniques. MicroCT demonstrates that
the normal partition between cortical bone and
marrow space is lost in tg mice, and that both
are replaced by a continuous plexus of cancel-
lous bone. Sections extend from 0.5 to 2.5 mm
below the physis.
Figure 2. Impaired development of adipose (yellow) marrow in COL1-caPPR
mice. Histology of the calcaneum at 2 wk and 3 mo. At 2 wk, the wt
marrow cavity contains red hematopoietic marrow (a) with scattered
adipocytes, and frequent multivacuolar, developing adipocytes (c and inset).
In tg mice, a distinct cavity is not observed, hematopoiesis and adipocytes
are absent, and an excess of bone is present (b and d). At 3 mo, hemato-
poiesis is no longer present, and the marrow cavity is filled with mature
adipocytes in wt mice (e). No cavity is present in tg mice, and only rare
adipocytes are found in narrow vascular spaces interrupting the continuity
of the excess bone (f). 
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ondary spongiosa was obvious at 1 mo, and continued thereaf-
ter. This process generated increasing amounts of marrow,
while leaving behind a system of trabeculae, which extended
well into the diaphysis of tg mice. Corresponding regions of the
same wt long bones featured a fully formed marrow cavity de-
void of trabecular structures. With time, a marrow cavity of
near-normal length was established at 4–5 mo in tg mice.
Occurrence of multiple remodeling cycles in the
extended primary spongiosa (“medullary bone”) originally
formed in lieu of marrow space in tg mice was confirmed by
histological studies (Fig. 4). Between 2 wk and 5 mo, fluores-
cence microscopy of hematoxylin and eosin (H&E)–stained
sections visualized complex arrays of cement/reversal lines
(each marking an individual remodeling cycle) within the med-
ullary trabeculae of tg mice (Fig. 4 d). At the same time, a
marked change in the morphology of cells residing on trabecu-
lar surfaces and within intertrabecular areas was observed. Al-
though osteoblasts of normal morphology lined the surface of
primary medullary bone trabeculae at 2 wk (Fig. 4 a), cells as-
sociated with medullary bone at 3 mo were uniformly spindle
shaped and fibroblastic in habit (Fig. 4 b). Together, cell mor-
phology, accumulation of fibrous tissue, and abnormal bone
structure compounded a dysplastic pattern reminiscent of hu-
man fibrous dysplasia (FD; Riminucci et al., 1997, 1999). The
relative length of the region occupied by dysplastic bone and
fibrous tissue decreased over time and was limited to a narrow
metaphyseal region at 4 mo. At 5 mo, a hematopoietic marrow
extended to the physis proper. However, throughout the metaph-
ysis, an overt excess of trabecular bone was demonstrated his-
tologically in tg mice, matching the radiographic analysis.
 
Reduced frequency and enhanced ex vivo 
expansion of CFU-F in skeletally mature 
Col1-caPPR mice
 
Because a significant alteration in postnatal development of
marrow was a key phenotypic trait of tg mice, we wanted to de-
termine whether these changes affected the composition and
functional properties of the marrow stromal cell population. To
this end, stromal cell strains were established in culture from
wt and tg mice at 5 mo (the age when a distinct marrow cavity
had formed from which stromal cells could be harvested from
Figure 3. Relative growth of marrow cavities with respect to bone over
time. High resolution radiograms of tibia and fibula at 1, 3, and 5 mo. At
1 mo, a much longer primary spongiosa is observed in tg mice than in wt
mice. In continuity with the extended primary spongiosa, abundant trabec-
ulae are detected in the medullary cavity of the diaphysis. Corresponding
regions in wt tibia show a bone-free marrow cavity. At 3 mo, a dense
primary spongiosa is still present in the tg tibia, albeit much reduced in
length compared with what is observed at 1 mo. Below this region, a marrow
cavity is discernible. However, it is occupied by a dense meshwork of
bone trabeculae. Corresponding regions in the wt tibia show a bone-free
marrow cavity. A similar pattern is observed at 5 mo. Asterisks mark
corresponding regions in the primary spongiosa, metaphysis, and diaphysis
in radiograms of wt and tg mice.
Figure 4. Transient fibrous dysplastic phase in bone and marrow of
Col1-PPR mice. (a and b) Transmitted light views of standard H&E-stained
sections of the proximal metaphysis of the tibia at 2 wk and 3 mo. The
medullary bone is lined by typical cuboidal osteoblasts (ob) at 2 wk (a),
and, although excessive, it is otherwise histologically normal. In contrast,
morphologically typical osteoblasts cannot be recognized, and only spindle-
shaped cells (sc) fill the spaces between trabeculae at 3 mo (b). The orien-
tation of trabeculae is more haphazard, giving the tissue a dysplastic
appearance. (c and d) Fluorescence microscopy images of the same sec-
tions. No cement lines (marks of bone remodeling events) are seen at 2 wk
(c), which is consistent with the primary nature of the medullary bone. A
complex pattern of cement lines (which remain nonfluorescent in H&E-
stained sections) is seen at 3 mo (d, arrows), testifying to the occurrence of
multiple remodeling cycles. 
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tg mice). The structure of the bones from which cells were de-
rived in culture was examined by high resolution radiographic
analysis. Corresponding bones of mice of the same age as those
used for establishing cell cultures were subjected first to the
same kind of radiographic analysis, and then to histological
analysis. This procedure demonstrated a much higher amount
of trabecular bone associated with the marrow of tg mice com-
pared with that of wt mice (Fig. 5 a). No difference in the cellu-
lar composition of hematopoietic tissue was histologically ap-
parent in tg mice.
Primary cultures were initiated by plating 
 
 
 
8 
 
 
 
 10
 
7
 
 nu-
cleated bone marrow cells. Because SSCs and OPs are both in-
cluded in the clonogenic subset of stromal cells (CFU-Fs), the
frequency of CFU-Fs at the time of explantation was deter-
mined by a colony-forming efficiency (CFE) assay (CFE
 
t0
 
), as
the number of CFU-Fs per 10
 
5
 
 nucleated bone marrow cells.
This demonstrated a significantly lower CFE (three- to four-
fold) in tg mice than in wt mice (Figs. 5 b and 6 a). Based on
the CFE assay, the total number of CFU-Fs plated in each high
density culture was calculated (CFU-F
 
t0
 
).
In primary culture, tg strains demonstrated a shorter dou-
bling time than wt strains (32.2 vs. 35.5 h, respectively). Over 17
d in culture, tg and wt strains underwent 12.6 and 11.5 population
doublings, respectively. At the end of ex vivo expansion, total cell
yield per initially plated CFU-F was 2.3-fold higher for tg strains
than for wt strains (6.8 
 
 
 
 10
 
3
 
 vs. 2.9 
 
 
 
 10
 
3
 
, respectively). The fre-
quency of CFU-Fs at the end of culture (before in vivo transplan-
tation) was assessed by enumerating the number of CFU-Fs,
which was done by plating 10
 
3
 
 cells per strain in 25-cm
 
2
 
 flasks
(CFE
 
tN
 
). At this time, the frequency of CFU-Fs in the total popu-
lation had become significantly higher (more than twofold) in tg
strains than in wt strains (Fig. 6 b). The total numbers of CFU-Fs
in wt and tg strains at the end of culture were then determined
based on CFE
 
tN
 
 and total cell yield, and ratioed to the total num-
ber of explanted CFU-Fs in each strain (CFU-F
 
tN
 
/CFU-F
 
t0
 
). This
revealed a mean 52.7-fold increase in CFU-Fs in wt strains, and
an average 290.2-fold increase in CFU-Fs in tg strains (an approx-
imately sixfold increase in tg strains compared with wt strains;
Fig. 6 c). Hence, threefold as many total cells, but approximately
sixfold as many CFU-Fs per single, originally explanted CFU-F,
were obtained for tg strains compared with wt strains over the
same time in culture. The CFU-Fs from tg mice expanded in cul-
ture to a greater extent, and generated more CFU-Fs per total
number of stromal cells, than those from wt mice.
 
The presence of OPs, but lack of SSCs, 
in the marrow of skeletally mature Col1-
caPPR mice
 
The ability of wt and tg cell strains to generate a complete hetero-
topic bone organ and establish a hematopoietic microenvironment
was tested with two different in vivo transplantation assays. We
Figure 5. Histology of the bone/marrow organ and CFU-F frequency in
mice at skeletal maturity. (a) Histology of the proximal metaphysis of the
tibia in wt and tg mice at 4.5 mo. Hematopoietic marrow now fills the
marrow cavity up to the physis in both wt and tg mice. A marked excess of
trabecular bone is observed in tg mice compared with in wt mice (unde-
calcified MMA sections, von Kossa staining). (b) Representative primary
cultures of cells established at clonal density from wt and tg mice. Note the
higher number of colonies (CFU-F) in wt cultures.
Figure 6. Frequency and expansion capabilities of CFU-F. (top) Frequency
of CFU-F at the time of explantation (t0). Results shown as number of colonies
per 10
5 nucleated bone marrow cells (mean of triplicate determinations
per mouse). The tg marrow is reduced in CFU-F, relative to the wt marrow
(analysis of variance [ANOVA], Scheffe’s F test 309.16* [significant at
95%], P   0.0001). (middle) Frequency of CFU-F at the end of ex vivo
expansion (day 17, tN). Results shown as number of colonies per 10
3 stromal
cells (mean of triplicate determinations per two cell strains per genotype).
Strains of tg mice are enriched in total CFU-F, relative to strains of wt mice
(ANOVA, Scheffe’s F test 94.03* [significant at 95%], P   0.0002).
(bottom) Fold increase in CFU-F over the culture period was calculated as
the ratio of the total number of CFU-Fs at the end of the culture period to
the total number of CFU-Fs in the marrow explants. Results based on tripli-
cate determinations in duplicate experiments (ANOVA, Scheffe’s F test
124.52* [significant at 95%], P   0.02). (top, middle, and bottom) Error
bars indicate SD of the mean. 
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performed transplants using either a mineral phase (hydroxy-
apatite/tricalcium phosphate [HA/TCP]) or a nonmineralized,
collagenous carrier. The two carriers differ with respect to their
osteoconductive properties. Whereas HA/TCP facilitates bone
deposition by cells competent for bone formation by providing a
preexisting mineralized scaffold (Damien and Parsons, 1991),
collagen, per se, does not. In 12 out of 12 transplants made with
wt strains and HA/TCP, bone, hematopoietic tissue, and adipo-
cytes were evident at all time points. In contrast, bone and fibrous
tissue, but neither hematopoietic tissue nor marrow adipocytes,
were formed in 12 out of 12 transplants of tg strains with HA/TCP
(Fig. 7 a). The amount of bone formed in the transplants was as-
sessed by histomorphometry and was found to be essentially the
same for wt and tg strains at all time points (Fig. 7 b).
Under nonosteoconductive conditions (transplants in col-
lagen sponges), in 12 out of 12 transplants, wt strains formed
complete ossicles, composed of a shell of cortical bone and a
marrow cavity with bone trabeculae; complete hematopoiesis
(granulo-, erythro-, and megakaryopoiesis); and adipocytes
(Fig. 8). Early developmental phases of bone and marrow for-
mation (deposition of bone by osteoblasts, adipogenesis, estab-
lishment of a sinusoidal vascular bed, and removal of the col-
lagen carrier) were well apparent in wt transplants harvested at
28 d, and formation of a fully structured ossicle was complete
at 56 d. In contrast, in spite of the high number of CFU-Fs
Figure 7. Osteogenic potential of stromal strains. (a) Histology of ectopic
ossicles formed subcutaneously in immunocompromised mice by strains
derived from wt and tg mice transplanted with an osteoconductive carrier
(HA/TCP particles; HA). Formation of bone (b) and marrow (bm) is obvious
in transplants of wt cells at 28, 42, and 56 d. Adipocytes in the hemato-
poietic marrow are evident at 42 and 56 d. Formation of bone, but not of
red marrow, is obvious in transplants of tg cells at 28, 42, and 56 d.
Adipocytes are not formed, and only fibrous tissue (ft) fills the spaces be-
tween bone surfaces. (b) Histomorphometric assessment of the amount of
bone (bone volume/total volume; BV/TV %) formed in ectopic ossicles did
not reveal differences between wt and tg strains at any time point. A similar
increase in the amount of bone was observed at 56 d compared with earlier
time points in wt and tg transplants. Error bars indicate SD of the mean.
Figure 8. Gross, radiographic, and histological analysis of subcutaneous
transplants of stromal strains in conjunction with collagen sponges. Gross
appearance of the transplants generated by wt (a and e) and tg (c and g)
strains harvested at 42 (a and c) and 56 d (e and g). Hematopoiesis gives
a red color to wt transplants (a and e), whereas the collagen sponge
remains pale gray in spite of vascularization (well apparent in c) in tg
transplants (c and g). High resolution radiograms of the same structures
for wt (b and f) and tg (d and h) transplants. Bone formation is readily
detected in wt transplants (b and f), and even a distinct bony cortex is easily
resolved in the ectopic ossicles. No bone was formed by tg cells (d and h).
(i and j) Nondecalcified sections stained with Goldner’s trichrome stain.
(k–n) Paraffin sections stained with H&E. (i–n) Examination of wt trans-
plants at 28 (i), 42 (k), and 56 d (m) revealed the progressive formation of
a complete heterotopic ossicle, including a bony cortex and a medullary
cavity with trabecular bone (*), and the establishment of a complete
hematopoietic marrow. Fully mature adipocytes (#) are well apparent by
day 42. Neither bone nor a hematopoietic marrow was present at any
time point in tg transplants (j, l, and n). 
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transplanted, tg strains consistently failed to establish a hetero-
topic bone organ upon transplantation (no ossicle formation
was observed in 12 out of 12 transplants of tg strains; Fig. 8).
Equal numbers of cells were used for all transplants.
Based on the frequency of CFU-Fs determined at the end of
the culture period (CFE
 
tN
 
), the number of CFU-Fs that were
actually transplanted was calculated to be 3–4 
 
 
 
 10
 
4
 
 for wt
strains, and 8–9 
 
 
 
 10
 
4
 
 for tg strains. The absolute number of
transplanted CFU-F was approximately twofold higher for tg
strains compared with wt strains. This ruled out the possibil-
ity that the impaired ability of tg strains to establish a com-
plete heterotopic bone organ in vivo was caused by an insuffi-
cient number of transplanted CFU-Fs, among which OPs and
SSCs are found.
These results indicate that OPs, assayable in vivo by
transplantation with an osteoconductive carrier (HA/TCP),
were present in both tg and wt CFU-F populations. Consider-
ing that fewer CFU-Fs were present in tg marrow than in wt
marrow, and that tg and wt strains formed similar volumes of
bone with HA/TCP in vivo, a greater potential for bone for-
mation could be estimated for tg CFU-Fs than for wt CFU-Fs.
Assayable multipotent cells (SSCs), defined as cells able
to regenerate a complete heterotopic bone/marrow organ in
vivo, regardless of the osteoconductive properties of the car-
rier used (HA/TCP vs. collagen), were represented in the wt
CFU-F population, as expected. In contrast, SSCs were either
present in insufficient number, or absent altogether, in the tg
CFU-F population. The greater expansion ex vivo of the tg
CFU-F population compared with that of the wt CFU-F popu-
lation was therefore not associated with multipotency in vivo.
These results are consistent with a proliferative effect of the
transgene on committed OPs, which are endowed with some
inherent potential for expansion but are neither multipotent
nor self-renewing (that is, they represent transit amplifying,
committed progenitors; Bianco and Robey, 2004).
 
Discussion
 
The transition from bone to marrow is 
altered in Col1-caPPR mice
 
Targeted expression of caPPR in the osteogenic lineage signifi-
cantly perturbs the development of the bone marrow. Normal
remodeling of the primary spongiosa into hematopoietic mar-
row during longitudinal bone growth suggests the transition
from a tissue where PPR is abundantly expressed (i.e., the pri-
mary spongiosa; Lee et al., 1993) to a tissue where global PPR
expression is low to undetectable (i.e., the bone marrow; Lee et
al., 1994; Calvi et al., 2001). In Col1-caPPR mice, constitutive
activity of PPR in the primary spongiosa results in generation
of excess bone in the presumptive marrow space, at the ex-
pense of the developing marrow cavity. As a consequence of
expression of caPPR in osteogenic cells, bone formation in the
primary spongiosa is enhanced, whereas establishment of mar-
row is delayed. This is associated with a reduced hematocrit in
mice 1–3 mo old (unpublished data).
The hematopoietic marrow includes specific hemato-
poiesis-supporting stromal cell types (Friedenstein et al.,
1974; Tavassoli and Yoffey, 1983), which must be estab-
lished during the transition from the primary spongiosa to he-
matopoietic marrow. These include, as a major cell type, re-
ticular cells (Westen and Bainton, 1979), which share several
phenotypic traits with osteogenic cells (Bianco and Rimi-
nucci, 1998), establish close physical contacts with hemato-
poietic cells (Westen and Bainton, 1979; Bianco and Boyde,
1993), and are able to convert to marrow adipocytes during
postnatal life (Bianco et al., 1988). Adipose conversion of re-
ticular cells underlies the formation of yellow marrow at spe-
cific anatomical sites (Tavassoli and Yoffey, 1983), a process
impaired, as we have shown, in Col1-caPPR mice. The devel-
opmental origin of reticular cells (and of the marrow adipo-
cytes arising from them) has not been fully elucidated, but
may be rooted in a local adaptation of osteogenic cells during
bone organogenesis (Bianco et al., 1999; Bianco and Robey,
2000). Our observations suggest that as a consequence of
caPPR expression in osteogenic cells, the establishment of
differentiated stromal cell phenotypes such as reticular cells
and adipocytes is perturbed, in the context of the delayed es-
tablishment of a marrow cavity and hematopoiesis.
 
The frequency and function of CFU-Fs 
are altered in Col1-caPPR mice
 
The clonogenic subset of adherent stromal cells (CFU-Fs) con-
tains a hierarchy of progenitors that can be assayed by in vivo
transplantation and that include a subset of multipotent, self-
renewing SSCs (which generate bone and nonhematopoietic
marrow elements upon transplantation), as well as a larger sub-
set of committed osteogenic progenitors (which generate bone
but do not support marrow formation upon transplantation)
(Friedenstein, 1980, 1990; Owen and Friedenstein, 1988; Bi-
anco and Robey, 2000, 2004).
We have shown that at 5 mo, there were fewer CFU-Fs in
the stroma of tg mice, but they exhibited a greater expansion
potential, than in wt mice. Committed OPs were present within
the CFU-F pool and assayable in vivo in tg mice: tg strains
formed bone when transplanted with an osteoconductive car-
rier (HA/TCP). However, the stroma of tg mice contained no
assayable multipotent SSCs: only bone, and no hematopoiesis-
supporting stroma or adipocytes, was formed by tg stromal
strains when they were transplanted with an osteoconductive
carrier; neither bone nor marrow was formed when the same
strains were transplanted with a nonosteoconductive carrier.
Obviously, an osteoconductive phase facilitates the deposition
of bone by cells that are fully competent for osteogenesis (Beg-
ley et al., 1993). Conversely, collagen sponges lack osteocon-
ductive properties and are removed from the transplant during
deposition of bone (Holmbeck et al., 1999). Thus, different os-
teogenic performances, perhaps ascribed to distinct subsets of
cells, are probed in transplantation assays with the two differ-
ent carriers.
 
Col1-caPPR mice are deficient in 
postnatal SSCs
 
Neither prenatal skeletal patterning and development, nor post-
natal osteoblast differentiation and function, appear to be de- 
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fective in Col1-caPPR mice. This implies that the skeleton of tg
mice develops from a normal repertoire of fetal skeletal pro-
genitor cells, and that the observed deficit of CFU-Fs harbored
in postnatal marrow is related to developmental events inherent
in bone marrow organogenesis, most of which is postnatal in
mouse long bones and is perturbed and delayed, as we have
shown, in Col1-caPPR mice.
The differences in frequency and properties of tg and wt
CFU-Fs at 5 mo are indeed established through a markedly differ-
ent in vivo history of bone as an organ. BrdU labeling and in situ
hybridization studies have shown that between 2 wk and 3 mo, in-
creased cell proliferation expands the pool of osteogenic cells in
the metaphyses of tg long bones (Calvi et al., 2001). As a result,
preosteoblastic, spindle-shaped cells expressing multiple osteo-
genic markers accumulate in trabecular spaces of tg mice (Calvi
et al., 2001). Later, when marrow stroma becomes directly assay-
able, a deficit of CFU-Fs (and an absence of assayable multipo-
tent SSCs) is observed in tg mice compared with wt mice.
Targeted expression of the transgene in committed osteo-
genic cells is fully consistent with a proliferative effect in the
same cells, but it would imply, per se, that there are no changes
in the number or function of “uncommitted” SSCs. The deficit
of assayable SSCs in Col1-caPPR mice, in contrast, implicates
them as direct or indirect targets of the transgene effect, which
depends on the activation of an osteoblast-specific promoter.
This supports the view that SSCs may be at least partially com-
mitted to osteogenic differentiation, and thus represent an inte-
gral part of the osteogenic lineage, rather than being uncommit-
ted cells (Bianco et al., 1999; Satomura et al., 2000).
Because self-renewal is a defining property of stem cells,
it would be expected that the size of the SSC population in the
postnatal marrow of tg mice would not be affected by an en-
hanced rate of proliferation in cells of the osteogenic lineage,
whether they included the multipotent SSCs or not. However, a
deficit in SSCs may be established through inadequate self-
renewal; for example, if the number of cell divisions evoked by
the effect of the transgene were to exceed the self-renewal ca-
pacity of SSCs. The magnitude of self-renewal of SSCs may be
tuned to the relatively low rate of bone turnover compared with
the magnitude of self-renewal of blood or epidermis, for exam-
ple. Self-renewal itself is hardly an absolute property, and fail-
ure of self-renewal may be ultimately observed in a variety of
tissues after prolonged phases of accelerated turnover. Indeed,
an increase in proliferative activity and in remodeling cycles is
observed in the bones of tg mice during the medullary bone
phase, before establishment of a CFU-F–deficient marrow.
Alternatively, inadequate self-renewal may be explained
based on current models of asymmetric kinetics of stem cell–
dependent populations (Sherley, 2002). In these models, self-
renewing and non–self-renewing types of cell divisions (asym-
metric vs. symmetric) may occur in stem cells in a stochastic
fashion (Watt and Hogan, 2000). The relative frequency of one
type of division versus the other determines preservation, ex-
pansion, or consumption of the stem and progenitor cell com-
partments (Sherley, 2002). One could thus speculate that the
transgene may alter the frequency of asymmetric versus sym-
metric division of SSCs, leading to expansion of the compart-
ment of committed OPs and consumption of SSCs proper. Con-
sistent with this interpretation, we observed that expansion of
tg CFU-Fs was not the same as that of wt CFU-Fs, with more
CFU-Fs being generated per initial clonogenic cell.
SSCs that would self-renew normally at a constant rate
would continue to replenish a compartment of committed OPs,
which would overexpand as an effect of the transgene, and sus-
tain unabated medullary bone formation. Thus, inadequate self-
renewal of stem cells might explain why the skeletal phenotype
of tg mice resolves over time. Calvi et al. (2001) have other-
wise documented the persistence of transgene expression in os-
teogenic/stromal cells of tg mice at 3 mo (when establishment
of a marrow cavity is well underway), dispelling the silencing
of the transgene as an alternative explanation for the timed
clearance of medullary bone in caPPR mice.
 
The interplay between HSCs and SSCs in 
the marrow
 
Calvi et al. (2003) have shown that tg osteogenic/stromal cells ap-
pear capable of supporting HSCs with greater efficiency than their
wt counterparts. As a result, the compartment of HSCs, but not of
hematopoietic progenitors and progeny thereof, is expanded in tg
mice at 3 mo. In skeletally mature tg mice, differentiated osteo-
genic/stromal cells in the marrow cavity support hematopoiesis in
vivo and in vitro (Calvi et al., 2003), whereas establishment of he-
matopoietic marrow is delayed in vivo, and SSCs capable of re-
forming hematopoiesis-supporting cells upon expansion ex vivo
and transplantation in vivo are not assayable among stromal cells.
Expression of caPPR in the osteogenic lineage may thus result in
different effects on HSC support versus the support of HSC prog-
eny and hematopoiesis proper. In addition, it results in opposing
effects on the two different stem cell compartments in bone mar-
row, HSCs and SSCs. In tg mice, increased numbers of HSCs, and
delayed birth and maturation of hematopoietic progenitors, are
mirrored in the osteogenic system by a deficiency of assayable
SSCs and a prolonged, sustained expansion of committed progen-
itors. A competitive interdependence of hematopoiesis and osteo-
genesis at the organ level is obvious in many instances of develop-
ment and disease, such as the development of inappropriate
porosity of bone caused by expansion of hematopoietic tissues in
congenital hemolytic anemias (Bianco and Riminucci, 1998). Our
data extend the competitive relationship of the two “strange bed-
fellows” (bone and marrow) to the level of stem cells. It follows
that a precisely timed modulation of osteogenesis is critical not
only for the establishment of marrow cavities and hematopoiesis,
but also for the establishment, at the same time, of an adequate
pool of SSCs in marrow, in a precise balance with the size of the
HSC compartment. Appropriate modulation of PPR signaling,
made impossible by caPPR in osteogenic cells, is essential for this
critical switch in bone and marrow organogenesis. Thus, PTH/
PTHrP signaling is a major regulator of the ontogeny of marrow
and its stromal tissue, and of the SSC compartment.
 
FD-like changes in bone and marrow of 
Col1-caPPR mice
 
We have also shown that a transient dysplastic phase occurs
during bone growth in Col1-caPPR mice, closely reminiscent 
PTH/PTH
 
R
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of changes observed in human diseases noted for derangements
in the PPR signaling pathway. These diseases include hyper-
parathyroidism (Bianco and Bonucci, 1991) and FD of bone
(OMIM [Online Mendelian Inheritance in Man] 174800), a ge-
netic disease in which Gs
 
 
 
, a downstream mediator of PPR
signaling, is constitutively active because of somatic mutations
(Riminucci et al., 1997). In these conditions, as in Col1-caPPR
mice, fibroblast-like cells with the phenotype of OPs accumulate
around bone trabeculae and replace normal marrow tissue. Inter-
estingly, stromal strains obtained from human FD marrow, like
those derived from Col1-caPPR mice, contain skeletal progeni-
tors that only form bone and fibrous tissue, and fail to establish
the hematopoietic microenvironment and adipocytes upon in
vivo transplantation (Bianco et al., 1998). The histological simi-
larities between the transient fibrous dysplastic phase of Col1-
caPPR mice and a human disease rooted in a dysfunction of the
same signaling pathway are thus matched by similar behavior of
skeletal progenitors when assayed in vivo. Col1-caPPR mice
may represent a unique model of the disease, noted as a disease
of the stromal stem/progenitor cell system (Bianco and Robey,
1999). Important predictions as to the role of PPR signaling and
its downstream mediators in regulating SSC kinetics can be
made based on analysis of Col1-caPPR mice and are currently
being tested by correlative studies of human SSCs in FD of bone.
 
Materials and methods
 
Col1-caPPR mice
 
Previously, mice were generated in which the mouse 2.3 Col1A1 pro-
moter (bone specific) was linked to 1,880 bp encoding the constitutively
active PPR-H223R sequence, along with 750 bp of the cloning vector pc-
DNAI (Calvi et al., 2001). Tg male mice were bred with wt female FVB/N
mice, and litters were harvested at various time points after birth. All stud-
ies were performed under institutionally approved animal protocols.
 
Transgene analysis
 
Genotyping was done as described previously (Calvi et al., 2001). Geno-
mic DNA was extracted and purified from tail clippings using a commer-
cial kit (QIAGEN), and 2 
 
 
 
l was diluted in 50 
 
 
 
l of PCR master mix
(Roche Diagnostics). PCR was performed using a forward primer from
the receptor sequence (5
 
 
 
-CACCTGCCCTGCTACAGGAAGAG-3
 
 
 
; nucle-
otides 423–445 from GenBank/EMBL/DDBJ under accession no. U22409)
and a reverse primer from the pcDNA1 vector in the transgene (5
 
 
 
-TTC-
CACCACTGCCTCCCATTCATC-3
 
 
 
). The samples were heated at 94
 
 
 
C for
1 min; and 30 cycles were performed at 94
 
 
 
C for 30 s, 58
 
 
 
C for 45 s,
72
 
 
 
C for 1 min, and 72
 
 
 
C for 3 min for termination. PCR products re-
solved by electrophoresis yielded a 350-bp product present only from ge-
nomic DNA from tg mice.
 
Skeletal imaging
 
Radiographic images of long bones were obtained (MX-20 Specimen Ra-
diography System; Faxitron X-ray Corp.) at an energy of 30 kV for 90 s
with X-OMAT TL film and processed by an automated X-ray film developer
(model M35A; Eastman Kodak Co.).
Microradiographic analysis was done on undecalcified bones that
were dehydrated in ethanol and embedded in an epoxy resin (Bianco et
al., 1985). 100–200-
 
 
 
m sections were generated with a microtome
equipped with a rotating diamond knife (model HM3505S; Leica). Con-
tact microradiographs were prepared using an X-ray generator (XRG
3000; Ital Structures), operated at 12 kV and 20 mA for 15 min, and high
resolution film (Eastman Kodak Co.). Fixed films were observed with a mi-
croscope (Axiophot; Carl Zeiss MicroImaging, Inc.).
Tibiae of 2-wk-old mice were analyzed by microCT (ScanCo mi-
croCT 10; ScanCo Medical) with 15-
 
 
 
m resolution. Images (at 1,024 by
1,024 pixels) were obtained using a microfocus X-ray beam (7-
 
 
 
m spot
size) at 50 kVp, 8 W (160 microAmps).
 
Histology
 
Lower limbs from mice at 2 wk and 2, 3, 4, and 5 mo were fixed in 4%
formaldehyde in PBS, pH 7.4. Samples were either undecalcified and pro-
cessed for methyl methacrylate (MMA) embedding or decalcified in neu-
tral solutions of 10% EDTA and embedded in paraffin. MMA sections
were stained with von Kossa/Giemsa or Goldner’s trichrome stain. Paraf-
fin sections were stained with H&E and viewed with transmitted light or by
fluorescence microscopy to visualize bone remodeling cycles (cement
lines; Bradbeer et al., 1994).
 
Cell culture, CFE, and ex vivo expansion
 
The entire marrow content of six long bones (two femora, two tibiae, and
two humeri) was harvested from 4.5-mo-old mice by flushing with 
 
 
 
-MEM
containing 20% lot-selected FBS, 2 mM glutamine, 100 mU/ml penicillin,
and 100 
 
 
 
g/ml streptomycin sulfate (Biofluids, Inc.).
Single cell suspensions were made by repeated pipetting and pas-
sage through syringe needles of decreasing gauge and through a cell
strainer (Becton Dickinson) to remove aggregates. The frequency of CFU-F
(CFE) in the marrow at 5 mo was estimated by plating the cells at clonal
density (10
 
6
 
 cells per 25-cm
 
2
 
 flask). Nonadherent cells were removed af-
ter 4 h by extensive washing, and adherent cells were incubated with me-
dium containing 10
 
7
 
 nucleated guinea pig marrow cells (irradiated with
6,000 cGy) as feeder cells. Cultures were fixed on day 9 with absolute
methanol and stained with methyl violet, and colonies (
 
 
 
50 cells) were
counted using a dissecting microscope (Kuznetsov and Gehron Robey,
1996). Colonies were counted using four cultures per animal, generated
from two wt and four tg mice. Statistical evaluation was performed with
analysis of variance and Scheffe’s F test.
Cultures of stromal cells for ex vivo expansion were established
from equal numbers of total nucleated bone marrow cells (
 
 
 
8 
 
 
 
 10
 
7
 
cells). Cells were expanded by serial passage and harvested on day 17
(P3). At the end of ex vivo expansion, 10
 
3
 
 cells from each strain were
plated in 25-cm
 
2
 
 flasks, and CFE was assessed again as described in the
previous paragraph.
 
In vivo transplantation assays
 
The ability of stromal strains from wt and tg mice to recapitulate a bone/
marrow organ was assessed with in vivo transplantation assays (Krebs-
bach et al., 1997). Ex vivo expanded cells were aliquoted at 2 
 
 
 
 10
 
6
 
and pelleted at 1,000 
 
g
 
. Half were resuspended in 1 ml of growth me-
dium, allowed to attach to 40 mg of HA/TCP particles (100–200  m;
Zimmer), and embedded in a secondary vehicle (fibrin gel). The other half
was resuspended in 30–50  l of growth medium and loaded into col-
lagen sponges (Gelfoam; Upjohn). Constructs were transplanted subcuta-
neously into 8–15-wk-old female bg-nu/nu-xid mice (Harlan Sprague
Dawley) and harvested at 4, 6, and 8 wk, fixed, X-rayed, and either de-
calcified and processed for paraffin embedding or processed undecalci-
fied for MMA embedding. Histological sections were stained with H&E
(paraffin sections) or Goldner’s trichrome (MMA sections). The amount of
bone formed was determined in undecalcified sections by measuring the
total bone volume per tissue volume with a semiautomatic image analyzer
(IAS 2000; Delta System), as described previously (Corsi et al., 2003).
Comparisons between groups were performed by one-way analysis of
variance, and post hoc comparison was performed with Scheffe’s F test.
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